A new recombinant factor VIII: from genetics to clinical use

A new recombinant factor VIII: from genetics to clinical use

Christoph Kannicht,1 Guido Kohla,1 Maya Tiemeyer,2 Olaf Walter,3 Helena Sandberg4 1Octapharma Biopharmaceuticals GmbH, Molecular Biochemistry, Berlin, Germany; 2Octapharma Biopharmaceuticals GmbH, Heidelberg, Germany; 3Octapharma AG, Lachen, Switzerland; 4CoaBio AB, Bromma, SwedenThe December 2014...

Full description

Bibliographic Details
Main Authors:	Kannicht C, Kohla G, Tiemeyer M, Walter O, Sandberg H
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-07-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/letter-a-new-recombinant-factor-viii-from-genetics-tonbspclini-peer-reviewed-article-DDDT

Similar Items

A new recombinant factor VIII: from genetics to clinical use
by: Santagostino E
Published: (2014-12-01)

Recombinant factor&nbsp;VIII in the management of hemophilia A: current use and future promise
by: Jerry S Powell
Published: (2009-05-01)

Factor VIII Fc Fusion Protein but not FVIII Drives Human Monocyte-Derived Dendritic Cell Activation via FcγRIIa
by: Christoph Kannicht, et al.
Published: (2020-02-01)

Development and characterization of recombinant ovine coagulation factor VIII.
by: Philip M Zakas, et al.
Published: (2012-01-01)

Potential role of a new PEGylated recombinant factor VIII for hemophilia A
by: Wynn TT, et al.
Published: (2016-06-01)

Status of Recombinant Factor VIII Concentrate Treatment for Hemophilia A in Italy: Characteristics and Clinical Benefits
by: Mario Schiavoni, et al.
Published: (2019-12-01)

Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII.
by: Jingyao Qu, et al.
Published: (2020-01-01)

Clinical utility of exemestane in the treatment of breast cancer 
by: Zucchini G, et al.
Published: (2015-05-01)

Interaction of recombinant factor VIII and the nonionic surfactant Tween 80 at interfaces
by: Joshi, Omkar
Published: (2012)

Characterization of the Recombinant Human Factor VIII Expressed in the Milk of Transgenic Swine
by: Hodges, William Anderson
Published: (2014)

Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIII
by: Philip M. Zakas, et al.
Published: (2020-02-01)

Characterization of B domain-deleted recombinant human factor VIII in transgenic swine
by: Yi-Chun Chang, et al.

Nonhomologous recombination in the human genome : deletions and insertions in the human factor VIII gene /
by: Woods-Samuels, Patricia
Published: (1989)

Development of continuous cultivation of CHO cells producing recombinant blood coagulation factor VIII
by: A. N. Morozov, et al.
Published: (2018-02-01)

Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
by: Chen Y, et al.
Published: (2020-12-01)

CLINICAL EFFICACY OF RECOMBINANT FACTOR VIII FC FUSION PROTEIN IN HAEMOPHILIA A PATIENT RECEIVING ON DEMAND TREATMENT ONLY
by: Saima Zahir, et al.
Published: (2021-02-01)

Clinical preference for factors in treatment of geriatric depression
by: Riepe MW
Published: (2014-12-01)

Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
by: Asaoka D, et al.
Published: (2015-03-01)

Laser Profilometry Aiding Smart Vehicle Control
by: Cosimo Patruno, et al.
Published: (2014-12-01)

The factor VIII-related antigen and antibodies to factor VIII
by: Kernoff, Peter B. A.
Published: (1974)

Zonisamide in the management of epilepsy in the elderly
by: Romigi A, et al.
Published: (2015-06-01)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
by: Yin J, et al.
Published: (2019-01-01)

Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders
by: Hashemi SJ, et al.
Published: (2019-03-01)

Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro
by: Masahiro Takeyama, et al.
Published: (2020-10-01)

Production of Lentiviral Vectors Encoding Recombinant Factor VIII Expression in Serum-Free Suspension Cultures
by: Angelo Luis Caron, et al.
Published: (2015-12-01)

Cervical Ossification of Ligamentum Flavum: Elaborating an Underappreciated but Occasional Contributor to Myeloradiculopathy in Aging Population Based on Synthesis of Individual Participant Data
by: Zhang B, et al.
Published: (2021-05-01)

Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
by: Jones PW
Published: (2015-03-01)

Factor VIII in health and disease - the relationship of VIII procoagulant (VIII:C) to VIII procoagulant antigen (VIII:CAg) in selected states
by: McLellan, David Sinclair
Published: (1985)

Medical cannabis ‒ the Canadian perspective 
by: Ko GD, et al.
Published: (2016-09-01)

NEW and CRITICAL MALESIAN PLANTS VIII *
by: a. j. g. h. kostermans
Published: (1969-03-01)

Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy
by: Zhang H, et al.
Published: (2015-08-01)

Sucrose-Formulated Recombinant Factor VIII Dosing Flexibility in Prophylaxis Regimens: Experience from Postmarketing Surveillance Studies
by: Thomas J. Humphries, et al.
Published: (2015-01-01)

Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
by: Maria T. Georgescu, et al.
Published: (2020-02-01)

Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant)
by: Ueda H, et al.
Published: (2020-12-01)

Evaluation of a Humor Training for Patients with Chronic Pain: A Randomized Clinical Trial
by: Kugler L, et al.
Published: (2021-10-01)

Psychometric properties of the Spanish version of the Clinical Outcomes in Routine Evaluation – Outcome Measure
by: Trujillo A, et al.
Published: (2016-06-01)

Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy
by: Daniela Paola Roggeri, et al.
Published: (2017-10-01)

Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasis
by: Zhang M, et al.
Published: (2015-06-01)

Spectra Optia® Apheresis System: current insights into clinical risks and benefits
by: Klink A, et al.
Published: (2018-12-01)

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
by: Pawelczyk T, et al.
Published: (2015-06-01)